Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Fischer

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 16, 2017
Quantitative analysis of lab-to-lab variability in Caco-2 permeability assaysJong Bong Lee, Atheer Zgair, Dhiaa A Taha, et al.
Chemistry & Biology|May 5, 2004
Structural determinants of CDK4 inhibition and design of selective ATP competitive inhibitorsCampbell McInnes, Shudong Wang, Sian Anderson, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Synthesis and biological activity of 2-anilino-4-(1H-pyrrol-3-yl) pyrimidine CDK inhibitorsShudong Wang, Gavin Wood, Christopher Meades, et al.
Molecular Cancer Therapeutics|January 20, 2005
Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouseBernard P Nutley, Florence I Raynaud, Stuart C Wilson, et al.
The Journal of Biological Chemistry|March 7, 2007
Classical anticytokinins do not interact with cytokinin receptors but inhibit cyclin-dependent kinasesLukás Spíchal, Vladimír Krystof, Martina Paprskárová, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 13, 2017
Novel selective β<sub>1</sub>-adrenoceptor antagonists for concomitant cardiovascular and respiratory diseaseJillian G Baker, Sheila M Gardiner, Jeanette Woolard, et al.
European Journal of Medicinal Chemistry|September 5, 2016
Design of nucleotide-mimetic and non-nucleotide inhibitors of the translation initiation factor eIF4E: Synthesis, structural and functional characterisationFadi Soukarieh, Matthew W Nowicki, Amandine Bastide, et al.
American Journal of Translational Research|September 21, 2016
Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicinesAtheer Zgair, Jonathan Cm Wong, Jong Bong Lee, et al.
Oncotarget|October 4, 2014
Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI-73Frankie Lam, Abdullahi Y Abbas, Hao Shao, et al.
Science Translational Medicine|October 11, 2013
Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected miceJulie A Moreno, Mark Halliday, Colin Molloy, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 16, 2017
Quantitative analysis of lab-to-lab variability in Caco-2 permeability assaysJong Bong Lee, Atheer Zgair, Dhiaa A Taha, et al.
Chemistry & Biology|May 5, 2004
Structural determinants of CDK4 inhibition and design of selective ATP competitive inhibitorsCampbell McInnes, Shudong Wang, Sian Anderson, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Synthesis and biological activity of 2-anilino-4-(1H-pyrrol-3-yl) pyrimidine CDK inhibitorsShudong Wang, Gavin Wood, Christopher Meades, et al.
Molecular Cancer Therapeutics|January 20, 2005
Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouseBernard P Nutley, Florence I Raynaud, Stuart C Wilson, et al.
The Journal of Biological Chemistry|March 7, 2007
Classical anticytokinins do not interact with cytokinin receptors but inhibit cyclin-dependent kinasesLukás Spíchal, Vladimír Krystof, Martina Paprskárová, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 13, 2017
Novel selective β<sub>1</sub>-adrenoceptor antagonists for concomitant cardiovascular and respiratory diseaseJillian G Baker, Sheila M Gardiner, Jeanette Woolard, et al.
European Journal of Medicinal Chemistry|September 5, 2016
Design of nucleotide-mimetic and non-nucleotide inhibitors of the translation initiation factor eIF4E: Synthesis, structural and functional characterisationFadi Soukarieh, Matthew W Nowicki, Amandine Bastide, et al.
American Journal of Translational Research|September 21, 2016
Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicinesAtheer Zgair, Jonathan Cm Wong, Jong Bong Lee, et al.
Oncotarget|October 4, 2014
Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI-73Frankie Lam, Abdullahi Y Abbas, Hao Shao, et al.
Science Translational Medicine|October 11, 2013
Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected miceJulie A Moreno, Mark Halliday, Colin Molloy, et al.
Pageof 12